Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Management of vitiligo

J J Nordlund1, R M Halder, P Grimes

  • 1Department of Dermatology, University of Cincinnati, Ohio.

Dermatologic Clinics
|January 1, 1993
PubMed
Summary

Vitiligo is an autoimmune disease causing melanocyte destruction, impacting skin, eyes, and hair. Therapeutic goals focus on restoring melanocytes to normalize skin structure and immune functions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improved Constraints on Primordial Gravitational Waves using Planck, WMAP, and BICEP/Keck Observations through the 2018 Observing Season.

Physical review letters·2021
Same author

International Initiative for Outcomes (INFO) for vitiligo: workshops with patients with vitiligo on repigmentation.

The British journal of dermatology·2018
Same author

Hypopigmented mycosis fungoides: a retrospective clinicohistopathologic study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2016
Same author

Histopathological progression of a mycosis fungoides mimic to classic vitiligo.

Journal of the European Academy of Dermatology and Venereology : JEADV·2014
Same author

Vitiligo: current medical and scientific understanding.

Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia·2011
Same author

Topical treatment and combination approaches for vitiligo: new insights, new developments.

Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia·2010

Area of Science:

  • Dermatology
  • Immunology
  • Cell Biology

Background:

  • Vitiligo is a depigmentation disorder of unknown etiology.
  • It results in the loss of melanocytes from the skin, mucous membranes, eyes, and hair follicles.
  • This melanocyte loss disrupts the normal structure and function of affected organs.

Purpose of the Study:

  • To outline the therapeutic objectives for vitiligo management.
  • To emphasize the primary goal of repigmentation for restoring normal epidermal morphology and function.

Main Methods:

  • This abstract does not detail specific methods.
  • It focuses on the disease characteristics and therapeutic aims.

Main Results:

  • Vitiligo leads to significant structural and functional alterations in affected tissues.
  • Successful repigmentation aims to restore normal epidermal morphology.

Conclusions:

  • Restoration of melanocytes is crucial for normalizing skin structure.
  • Repigmented skin is expected to regain its normal immune and inflammatory functions.

Related Experiment Videos